Position in JNJ
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$15,929,665
+$4,306,733 QoQ
Shares Held
65,168
+16.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Artemis Investment Management LLP holds $1,107,485,466 across 8 Drug Manufacturers - General names. JNJ ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,444,565 | $284,897,109 | |
| 2 | ABBV |
AbbVie Inc.
|
1,041,483 | $226,512,137 | |
| 3 | PFE |
Pfizer Inc
|
7,392,508 | $207,581,624 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,885,298 | $174,993,323 | |
| 5 | BIIB |
Biogen Inc.
|
571,571 | $104,786,111 | |
| 6 | LLY |
ELI LILLY & Co
|
92,854 | $85,404,323 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
65,168 | $15,929,665 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
52,961 | $7,381,174 |
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,929,665 | 65,168 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $11,622,932 | 56,163 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $5,923,612 | 31,947 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,637,490 | 30,360 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,034,902 | 30,360 | Shares | Sole | 2025-04-24 | |
| 2024-03-31 | $8,587,344 | 54,285 | Shares | Sole | 2024-04-16 | |
| 2023-06-30 | $45,367,542 | 274,091 | Shares | Sole | 2023-07-19 | |
| 2022-03-31 | $13,436,515 | 75,814 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $22,411,839 | 138,773 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $21,450,465 | 130,208 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $37,806,580 | 230,037 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $28,706,426 | 182,402 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $105,135,185 | 706,174 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $102,867,188 | 731,474 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $106,457,890 | 811,850 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||